Consumptive coagulopathy in the ICU
Andrew Retter1, Beverley J Hunt2
1Guy's and St. Thomas' NHS Foundation Trust, London, UK.
Hematology. American Society of Hematology. Education Program
|December 9, 2023
Summary
Consumptive coagulopathy involves the loss of clotting factors, increasing bleeding risk. This review clarifies its broad definition, including disseminated intravascular coagulation (DIC) and extracorporeal circuits, for critical care management.
Area of Science:
- Critical care medicine
- Hematology
- Pathophysiology
Background:
- Consumptive coagulopathy is defined as a loss of hemostatic factors, increasing bleeding risk.
- Recent literature has conflated this term with disseminated intravascular coagulation (DIC).
- This review adopts a broader definition encompassing various causes of hemostatic factor depletion.
Approach:
- Review of current understanding of pathophysiology, diagnosis, and management.
- Focus on recent advances and controversies in consumptive coagulopathy.
- Emphasis on DIC and the impact of extracorporeal circuits on hemostasis.
Key Points:
- Consumptive coagulopathy encompasses conditions from major hemorrhage to DIC.
- Disseminated intravascular coagulation (DIC) involves simultaneous thrombosis and bleeding.
- Modern medical technology, like ECMO, significantly impacts hemostasis.
Conclusions:
- Clarifying the definition of consumptive coagulopathy is crucial for accurate diagnosis and management.
- Understanding DIC pathophysiology and management is vital in critical care.
- The influence of extracorporeal technologies on hemostasis requires further investigation.
Related Concept Videos
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
708
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
708
01:09Coagulation
6.8K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
6.8K
01:24Disorders of Hemostasis
922
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
922
01:05Introduction to Hemostasis
8.0K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
8.0K
01:20Extrinsic and Intrinsic Pathways of Hemostasis
7.9K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
7.9K